[go: up one dir, main page]

ZA95956B - The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 - Google Patents

The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6

Info

Publication number
ZA95956B
ZA95956B ZA95956A ZA95956A ZA95956B ZA 95956 B ZA95956 B ZA 95956B ZA 95956 A ZA95956 A ZA 95956A ZA 95956 A ZA95956 A ZA 95956A ZA 95956 B ZA95956 B ZA 95956B
Authority
ZA
South Africa
Prior art keywords
interleukin
disorders
drugs
treatment
serum level
Prior art date
Application number
ZA95956A
Inventor
Roswitha Stenzel
Martin Kaul
Lothar Daum
Joachim Kempeni
Christa Raab
Sibylle Schaefer
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA95956B publication Critical patent/ZA95956B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA95956A 1994-02-07 1995-02-07 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 ZA95956B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4403669 1994-02-07

Publications (1)

Publication Number Publication Date
ZA95956B true ZA95956B (en) 1995-10-11

Family

ID=6509608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95956A ZA95956B (en) 1994-02-07 1995-02-07 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6

Country Status (5)

Country Link
KR (1) KR100414505B1 (en)
DE (2) DE4409513C1 (en)
RU (1) RU2197990C2 (en)
UA (1) UA46731C2 (en)
ZA (1) ZA95956B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2271221C2 (en) * 2004-04-20 2006-03-10 Атикат Магомедхановна Герейханова Method for treating sepsis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631229A1 (en) * 1986-09-13 1988-03-24 Basf Ag MONOCLONAL ANTIBODIES AGAINST HUMAN TUMORNESCROSE FACTOR (TNF) AND THEIR USE
WO1991007986A1 (en) * 1989-12-04 1991-06-13 Schering Corporation Method of treating septic shock
RU2005489C1 (en) * 1990-06-25 1994-01-15 Попов Владимир Иванович Method for treating acute sepsis

Also Published As

Publication number Publication date
DE59510625D1 (en) 2003-05-08
UA46731C2 (en) 2002-06-17
DE4409513C1 (en) 1995-10-19
RU2197990C2 (en) 2003-02-10
KR100414505B1 (en) 2004-03-30

Similar Documents

Publication Publication Date Title
FI963101A7 (en) Use of anti-TNF antibodies as a drug for the treatment of diseases in which serum interleukin-6 levels are elevated
US5443960B1 (en) Method for the diagnosis of blood coagulation disorders
EP0088900A3 (en) Device for purifying the blood from metabolism substances
FR2714848B1 (en) Microcapsules and methods for their preparation.
EP0749306A4 (en) Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EP0649307A4 (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
EP0651639A4 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
DE3862585D1 (en) THERAPY DEVICE FOR REFRIGERATION APPLICATION.
AU7992994A (en) Immunoassay for the dectection of human autoantibodies
HUP9602570A2 (en) Process for producing immunoglobulines from fractions produced with fractioning human blood-plasma
DK132884D0 (en) PROCEDURE FOR PROVIDING RELATIONSHIP WITH Kidney or Urinary Disorders through the Skin
DE59500727D1 (en) Device for the production of infusion drinks
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
GB2216412B (en) Interleukin-6 molecule for the treatment of bone-related diseases
DZ2012A1 (en) Benzamides for the treatment of neurological degenerations.
ZA95956B (en) The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
IL112839A0 (en) Methods for the purification of halofluorocarbons
AU4419589A (en) Device for allowing the emanation of aromas or essential oils
AU1935595A (en) Methods of determining the gender of poultry
SI0804236T1 (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
FR2626961B3 (en) CUP FOR CANDLES
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
FI972193L (en) Process for the preparation of halomethylbenzoyl cyanides